✦ LIBER ✦

A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice

✍ Scribed by Shukla, V.; Zheng, Y.-L.; Mishra, S. K.; Amin, N. D.; Steiner, J.; Grant, P.; Kesavapany, S.; Pant, H. C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A survey of Cdk5 activator p35 and p25 l

✍ Huang-Chun Tseng; Ying Zhou; Yong Shen; Li-Huei Tsai 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 107 KB

The Involvement of Cdk5 Activator p35 in

✍ Hsiao, Ya-Hsin; Chen, Po See; Chen, Shun-Hua; Gean, Po-Wu 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 684 KB

P2-120 APP-related pathology in a P25/CD

✍ Dohoon Kim; Jonathan C. Cruz; Roderick T. Bronson; Li-Hueri Tsai 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

P1-409: Knockdown of plasminogen activat

✍ Liu, Rui-Ming; van Groen, Thomas; Kadish, Inga; Li, Ling; Katre, Ashwini; Hu, Ke 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.5.a.008 Effects of clinically approved

✍ Kelley, J.; Raeymaekers, L.; Ahnaou, A.; Babiloni, C.; Czech, C.; Dix, S.; Richa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P1-062: Tau reduction prevents epileptif

✍ Erik D. Roberson; William J. Meilandt; Jinghua Yao; Jong Yoo; Jeffrey L. Noebels 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB